Literature DB >> 9280218

The biology of lung cancer.

D P Carbone1.   

Abstract

Lung cancer is the most common cause of cancer death in the United States among both men and women, with an estimated 177,000 new cases and 159,000 deaths in 1996. Its overall incidence is increasing, particularly in women, and despite many complex and aggressive approaches to therapy, and great strides in understanding its biology and etiology, corresponding improvements in outcome are not yet apparent. This article will summarize the state of knowledge of the biology and genetics of lung cancer. These and future advances in our knowledge will certainly provide the foundation for future advances in therapeutics.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9280218

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  6 in total

1.  Quantitative fluorescence in situ hybridization in lung cancer as a diagnostic marker.

Authors:  K Truong; M Gerbault-Seureau; M N Guilly; P Vielh; G Zalcman; A Livartowski; A Chapelier; M F Poupon; B Dutrillaux; B Malfoy
Journal:  J Mol Diagn       Date:  1999-11       Impact factor: 5.568

Review 2.  Molecular understanding of lung cancers-A review.

Authors:  Chinnappan Ravinder Singh; Kandasamy Kathiresan
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

3.  MALDI-MS derived prognostic protein markers for resected non-small cell lung cancer.

Authors:  Baogang J Xu; Adriana L Gonzalez; Takefumi Kikuchi; Kiyoshi Yanagisawa; Pierre P Massion; Huiyun Wu; Stephen E Mason; Sandy J Olson; Yu Shyr; David P Carbone; Richard M Caprioli
Journal:  Proteomics Clin Appl       Date:  2008-09-10       Impact factor: 3.494

4.  Gammaaminobutyric acid A receptor alpha 3 subunit is overexpressed in lung cancer.

Authors:  Yan Liu; Fengjie Guo; Miao Dai; Di Wang; Yongqing Tong; Jian Huang; Jinyue Hu; Guancheng Li
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

5.  Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis.

Authors:  Wei-Min Gao; Rork Kuick; Randal P Orchekowski; David E Misek; Ji Qiu; Alissa K Greenberg; William N Rom; Dean E Brenner; Gilbert S Omenn; Brian B Haab; Samir M Hanash
Journal:  BMC Cancer       Date:  2005-08-23       Impact factor: 4.430

6.  Identification of a 170-kDa protein over-expressed in lung cancers.

Authors:  R Pincheira; Q Chen; J T Zhang
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.